The Dilated Aorta in Patients With Congenital Cardiac Defects

Journal of the American College of Cardiology

Volumn 53, Issue 6, 2009, Pages 461-467

  Yetman, Anji T ^a   Graham, Thomas ^b  

^a Adult Congenital Cardiology Program   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

aneurysm; aorta; dissection

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXYCYCLINE; TRANSFORMING GROWTH FACTOR BETA1;

AORTA COARCTATION; AORTA DILATATION; AORTA DISEASE; AORTA DISSECTION; CONGENITAL HEART DISEASE; DRUG MECHANISM; EMBRYO DEVELOPMENT; FALLOT TETRALOGY; GENE MUTATION; GREAT VESSELS TRANSPOSITION; HUMAN; INCIDENCE; MARFAN SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY ARTERY DISSECTION; PULMONARY VASCULAR DISEASE; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; UNSPECIFIED SIDE EFFECT;

AORTIC DISEASES; DILATATION, PATHOLOGIC; HEART DEFECTS, CONGENITAL; HUMANS; MARFAN SYNDROME; TRANSFORMING GROWTH FACTOR BETA;

EID: 59249104726     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.10.035     Document Type: Review

References (57)

1. Niwa K., Siu S.C., Webb G.D., and Gatzoulis M.A. Progressive aortic root dilatation in adults later after repair of tetralogy of Fallot. Circulation 106 (2002) 1374-1378
2. McMahon C.J., Ravekes W.J., Smith E.O., et al. Risk factors for neo-aortic root enlargement and aortic regurgitation following arterial switch operation. Pediatr Cardiol 25 (2004) 329-335
3. Tzemos N., Therrien J., Yip J., et al. Outcomes in adults with bicuspid aortic valves. JAMA 300 (2008) 1317-1325
4. Oliver J.M., Gallego P., Gonzalez A., Aroca A., Bret M., and Mesa J.M. Risk factors for aortic complications in adults with coarctation. J Am Coll Cardiol 44 (2004) 1641-1647
5. Ono M., Goerler H., Boethig D., Westhorr-Bleck M., Hartung D., and Breymann T. Valve-sparing operation for aortic root aneurysm late after Mustard procedure. Ann Thorac Surg 83 (2007) 2224-2226
6. Holman E. The obscure physiology of poststenotic dilatation; its relation to the development of aneurysms. J Thorac Surg 28 (1954) 109-133
7. Friedman T., Mani A., and Elefteriades J.A. Bicuspid aortic valve: clinical approach and scientific review of a common clinical entity. Expert Rev Cardiovasc Ther 6 (2008) 235-248
8. Silverman D.I., Burton K.J., Gray J., et al. Life expectancy in the Marfan syndrome. Am J Cardiol 75 (1995) 157-160
9. Dietz H.C., Cutting G.R., Pyeritz R.E., et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352 (1991) 337-339
10. Fedak P.W., de Sa M.P., Verma S., et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilation. J Thorac Cardiovas Surg 126 (2003) 797-806
11. Jones J.A., Barbour J.R., Stroud R.E., et al. Altered transforming growth factor-beta signaling in a murine model of thoracic aortic aneurysm. J Vasc Res (2008) 457-468
12. Erdheim J. Medionecrosis aortae idiopathica cystic. Virchows Arch Pathol Anat 276 (1930) 187-229
13. Niwa K., Perloff J.K., Bhuta S.M., et al. Structural abnormalities of great arterial walls in congenital heart disease. Circulation 103 (2001) 393-413
14. Huang P., Wang H.W., Li Y., et al. Expression of fibrillin-1 in congenital bicuspid aortic valves. Zhonghua Yi Xue Za Zhi 87 (2007) 1549-1552
15. Ruigrok Y.M., Rinkel G.J., van't Slot R., Wolfs M., Tang S., and Wijmenga C. Evidence in favor of the contribution of genes involved in the maintenance of the extracellular matrix of the arterial wall to the development of intracranial aneurysms. Hum Mol Genet 15 (2006) 3361-3368
16. Ikonomidis D., Jones J.A., Barbour J.R., et al. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome. Circulation 114 (2006) I365-I370
17. Gordon K.J., and Blobe G.C. Role of transforming growth factor-β superfamily signaling pathways in human disease. Biochimica et Biophysica Acta 1782 (2008) 197-228
18. Habashi J.P., Judge D.P., Holm T.M., et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 (2006) 117-121
19. Chaudhry S.S., Cain S.A., Morgan A., Dallas S.L., and Shuttleworth A. Fibrillin-1 regulates the bioavailability of TGFb-1. J Cell Biol 176 (2007) 355-367
20. Wang J., Nagy A., Larsson J., et al. Defective ALK5 signaling in the neural crest leads to increased postmigratory neural crest apoptosis and severe outflow tract defects. BMC Dev Biol 6 (2006) 51-60
21. Schievink W.I., and Mokri B. Familial aorto-cervicocephalic arterial dissections and congenitally bicuspid aortic valve. Stroke 26 (1995) 1935-1940
22. Schievink W.I., Mokri B., Piepgras D.G., and Gittenberger-de-Groot A.C. Intracranial aneurysms and cervicocephalic arterial dissections associated with congenital heart disease. Neurosurgery 39 (1996) 685-689
23. Nollen G.J., Groenink M., Tijssen J.G., et al. Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Eur Heart J 25 (2004) 1146-1152
24. Nistri S., Grande-Allen J., Noale, et al. Aortic elasticity and size in bicuspid aortic valve syndrome. Eur Heart J 29 (2008) 472-479
25. Senzaki H., Iwamoto Y., Ishido H., et al. Arterial haemodynamics in patients after repair of tetralogy of Fallot: influence on left ventricular after load and aortic dilation. Heart 94 (2008) 70-74
26. McKusick V.A., Logue R.B., and Bahnson H.T. Association of valvular disease and cystic medial necrosis of the ascending aorta; report of four instances. Circulation 16 (1957) 188-194
27. Mckusick V.A. Association of congenital bicuspid aortic valve and Erdheim's cystic medial necrosis. Lancet 1 (1972) 1026-1027
28. Borger M.A., Preston M., Ivanov J., et al. Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease?. J Thorac Cardiovasc Surg 128 (2004) 677-683
29. Beroukhim R.S., Kruzick T.L., Taylor A.L., Gao D., and Yetman A.T. Progression of aortic dilation in children with a functionally normal bicuspid aortic valve. Am J Cardiol 98 (2006) 828-830
30. Davies R.R., Kaple R.K., Mandapati D., et al. Natural history of ascending aortic aneurysm in the setting of an unreplaced bicuspid aortic valve. Ann Thorac Surg 83 (2006) 1338-1344
31. Boyer J.K., Gutierrez F., and Braverman A.C. Approach to the dilated aortic root. Curr Opinion Cardiol 19 (2004) 563-569
32. Matura L.A., Ho V.B., Rosing D.R., and Bondy C.A. Aortic dilatation and dissection in Turner syndrome. Circulation 116 (2007) 1663-1670
33. Davies R.R., Gallo A., Coady M.A., et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg 81 (2006) 169-177
34. Beroukhim R.S., Roosevelt G., and Yetman A.T. Comparison of the pattern of aortic dilation in children with the Marfan's syndrome versus children with a bicuspid aortic valve. Am J Cardiol 98 (2006) 1094-1095
35. Januzzi J.L., Isselbacher E.M., Fattori R., et al. Characterizing the young patient with aortic dissection: results from the international registry of aortic dissection (IRAD). J Am Coll Cardiol 43 (2004) 665-669
36. Bonow R.O., Carabello B., Chatterjee K., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 48 (2006) e1-e148
37. Pasquali S.K., Shera D., Wernovsky G., et al. Midterm outcomes and predictors of reintervention after the Ross procedure in infants, children, and young adults. J Thorac Cardiovasc Surg 133 (2007) 893-899
38. Brown J.W., Ruzmetov M., Rodefeld M.D., Mahomed Y., and Turrentine M.W. Incidence of and risk factors for pulmonary autograft dilation after Ross aortic valve replacement. Ann Thorac Surg 83 (2007) 1781-1787
39. Vogt M., Kuhn A., Baumgartner D., et al. Impaired elastic properties of the ascending aorta in newborns before and early after successful coarctation repair: proof of a systemic vascular disease of the prestenotic arteries?. Circulation 111 (2005) 3269-3273
40. Cohen M., Fuster V., Steele P.M., et al. Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation 80 (1989) 840-845
41. Peters R.M. Total repair of tetralogy of Fallot and replacement of aortic valve with Starr-Edwards prosthesis. Case report. J Thorac Cardiovasc Surg 61 (1971) 599-601
42. Jonsson H., Ivert T., and Brodin L.A. Echocardiographic findings in 83 patients 13-26 years after intracardiac repair of tetralogy of Fallot. Eur Heart J 69 (1995) 1255-1263
43. Tan JL, Davlouros PA, McCarthy KP, Gatzoulis MA, Ho SY. Intrinsic histologic abnormalities of aortic root and ascending aorta in tetralogy of Fallot 2005;112:961-8.
44. Niwa K. Aortic root dilatation in tetralogy of Fallot long-term after repair-histology of the aorta in tetralogy of Fallot: evidence of intrinsic aortopathy. Int J Cardiol 103:117-9.
45. Cohen M.S., and Wernovsky G. Is the arterial switch operation as good over the long term as we thought it would be?. Cardiol Young 16 (2006) 117-124
46. Schwartz M.L., Gauvreau K., del Nido P., Mayer J.E., and Colan S.D. Long-term predictors of aortic root dilation and aortic regurgitation after arterial switch operation. Circulation 110 (2004) 128-132
47. Mcmahon C.J., Nihill M.R., and Denfield S. Neoartic root dilation associated with left coronary stenosis following arterial switch procedure. Pediatr Cardiol 24: (2003) 43-46
48. Agnoletti G., Ou P., Celermajer D.S., et al. Acute angulation of the aortic arch predisposes a patient to ascending aortic dilation and aortic regurgitation late after the arterial switch operation for transposition of the great arteries. J Thorac Cardiol Surg 135 (2008) 568-572
49. Gutierrez P.S., Binotto M.A., Aiello V.D., and Mansur A.J. Chest pain in an adult with truncus arteriosus communis. Am J Cardiol 93 (2004) 272
50. Le Bret E., Lupoglazoff J.M., Bachet, et al. Pulmonary artery dissection and rupture associated with an aortopulmonary window. Ann Thorac Surg 78 (2004) e67-e68
51. Khush K.K., Randhawa R., and Israel E. A full house: complications from an uncorrected patent ductus arteriosus. Curr Cardiol Rep 7 (2005) 310-313
52. Gersony D.R., McClaughlin M.A., Jin Z., and Gersony W.M. The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis. Int J Cardiol 114 (2007) 303-308
53. Yetman A.T., Bornemeier R.A., and McCrindle B.W. Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am J Cardiol 95 (2005) 1125-1127
54. Ahimastos A.A., Aggarwal A., D'Orsa K.M., et al. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA 298 (2007) 1539-1547
55. Redondo S., Ruiz E., Padilla E., Gordillo-Moscoso A., and Tejerina T. Role of TGFβ-1 in vascular smooth muscle cell apoptosis induced by angiotensin II. Eur J Pharm 556 (2007) 36-44
56. Nagashima H., Uto K., Sakomura Y., et al. An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats. J Vasc Surg 36 (2002) 818-823
57. Chung A.W.Y., Yang H.H.C., Radomski M.W., and van Breemen C. Long term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circulation Res 102 (2008) 1-13